By Eric Schweibenz
On August 16, 2011, ALJ Robert K. Rogers, Jr. issued the public version of Order No. 15 (dated August 16, 2011) in Certain Gemcitabine and Products Containing Same (Inv. No. 337-TA-766).  

According to the Order, ALJ Rogers granted a joint motion filed by Complainant Eli Lilly and Company (“Lilly”) and Respondents Hospira, Inc. (“Hospira”) and Intas Pharmaceuticals, Ltd. (“Intas”) to terminate the investigation based on settlement agreements between Lilly and Hospira and Lilly and Intas (the “Agreements”).  After reviewing the confidential and non-confidential versions of the Agreements, ALJ Rogers granted the joint motion filed by Lilly, Hospira and Intas.